BrainStorm Cell Therapeutics
BCLI
#10185
Rank
โ‚ฌ5.98 M
Marketcap
1,05ย โ‚ฌ
Share price
-6.50%
Change (1 day)
-88.33%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of September 2024 : โ‚ฌ0.76 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is โ‚ฌ0.76 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31โ‚ฌ3.81 M-14.92%
2021-12-31โ‚ฌ4.48 M-23.57%
2020-12-31โ‚ฌ5.86 M177.81%
2019-12-31โ‚ฌ2.11 M
2018-12-31N/A
2010-12-31โ‚ฌ0.1 M-60.12%
2009-12-31โ‚ฌ0.25 M-18.5%
2008-12-31โ‚ฌ0.31 M-69.98%
2007-12-31โ‚ฌ1.05 M23.68%
2006-12-31โ‚ฌ0.85 M
2006-03-31โ‚ฌ0.4 M
2004-03-31โ‚ฌ0.02 M29.85%
2003-03-31โ‚ฌ0.01 M67.17%
2002-03-31โ‚ฌ0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
โ‚ฌ24.36 B 3,175,999.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.71 B 93,678.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 13,394.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.04 B 788,282.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ86.54 M 11,180.62%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA